Quick Answer
SELLAS Life Sciences Group, Inc. reported Long Term Debt of $0.00 for the year ending 2018.
- SELLAS Life Sciences Group, Inc. showed a decrease of -100.0% in Long Term Debt from 2017 to 2018.
- This data is from SELLAS Life Sciences Group, Inc.'s annual report (Form 10-K), filed with the SEC on March 22, 2019.
- XBRL data for this metric is available from 2012 to 2018 (6 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2013: $9.40 million | Q3 2013: $8.58 million | Q1 2014: $6.88 million | Q2 2014: $6.00 million | Q3 2014: $5.10 million | Q1 2015: $3.53 million | Q2 2015: $2.55 million | Q3 2015: $1.53 million | Q1 2018: $1.15 million | Q2 2018: $0.00 | Q3 2018: $0.00.
- Historical annual values: Fiscal year 2018: $0.00 | Fiscal year 2017: $2.61 million | Fiscal year 2015: $0.00 | Fiscal year 2014: $4.49 million | Fiscal year 2013: $7.74 million | Fiscal year 2012: $0.00.
- Data sourced from SEC EDGAR public filings as of August 8, 2026.
Last verified: